123. Crile, G. Jr. Changing end results in patients with papillary carciSurg. Gynecol. Obstet. 132: 460-8 (1971). noma of the thyroid. Nonencapsulated scler- 124, Hazard, J.B., Crile, G. Jr., and Dempsey, W.S. 125. Franssila, K.O. Prognosis in thyroid carcinoma. Cancer 36: 1138-46 (1975). Hazard, J.B. Small papillary carcinoma of the thyroid: A study with 126. 127. 128. 129, 130. 131. osing tumors of the thyroid. J. Clin. Endocrinol. 9: 1215 (1949). Invest. 9: 86-97 (1960). Klinck, G.H. and Winship, T. roid. Cancer 8: 701 (1955). Williams, E.D. 757-9 (1975). Occult sclerosing carcinoma of the thy- The pathology of thyroid malignancy. . Br. J. Surg. 62: Sampson, R.J., Oka, H., Key, C.R., Buncher, C.R., and Iijima, S. Metastases from occult thyroid carcinoma: An autopsy study from Hiroshima and Nagasaki, Japan. Cancer 25: 803-11 Sawin, C.T. and Hershman, J.M. The TSH response to thyrotropin- (1970). Fukunaga, F.H. and Yatani, R. Geographic pathology of occult thyroid carcinomas. Cancer 36: 1095-9 (1975). releasing hormone (TRH) in young adult men: Intra-individual variation and relation to basal serum TSH and thyroid hormones. 132. 133. 134. Lab. special reference to so-called nonencapsulated sclerosing tumor. J. Clin. Endocrinol. Metab. 46: 217 (1978). Thein-Wai, W. and Larsen, P.R. Effects of weekly thyroxine administration on serum thyroxine and 3,5,3'-triiodothyronine, thyrotropin and thyrotropin response to thyrotropin-releasing hormone. Endocrinol. Metab. 50: 660 (1980). J. Clin. Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P.A. The spectrum of thyroid disease in a community: The Wickham survey. Clin. Endocrinol. 7: 481 (1977). Van Middlesworth, L. Factors influencing the thyroid uptake of iodine isotopes from nuclear fission: A review. Health Phys. 9: 1197-1211 (1963). 135. Evans, T.C., Kretzchmar, R.H., Hodges, R.E., and Song, C.W. Radioiodine uptake studies of the human fetal thyroid. J. Nucl. Med. 8: 157-60 136. Hodges, R.E., Evans, T.C., Bradbury, J.T., and Keettel, W.C. (1967). ~ mulation of radioactive iodine by human fetal thyroids. Endocrinol. Metab. 15: 661-7 (1955). The accu- J. Clin. 137. 138. Mays, C.W. (University of Utah), Personal communication, 1974. Russel, K.P., Rose, H., and Starr, P. The effects of radioactive iodine in maternal and fetal thyroid function during pregnancy. Surg. Gynecol. 139. Fisher, W.D., Voorhess, M.L., and Gardner, L.I. Congenital hypothyroid- of environmental radioisotope contamination. Pediat. 62: 140. Obstet. 104: 560-4 (1957). ism in infant following maternal qi3l therapy, with a review of hazards (1963). Hamill, G.C., Jarman, J.A., and Wynne, M.D. J. _ 132-46 Fetal effects of radio- active iodine therapy in a pregnant woman with thyroid cancer. Obstet. Gynecol. 81: 1018-23 (1961). - 96 - Am. J.